Pharmacology and Obesity Treatment
Moving in JAMA.
- Moved, week to 23 Oct 2026
- 1
- Papers in 60 days
- 9
Rebuilt
Moved this week
Latest in Pharmacology and Obesity Treatment
Newest first · last 60 days
Obesity affects 15% of US children aged 2 to 5 years and 22% of those aged 6 to 11 years, and is linked to chronic diseases and reduced quality of life.
Digital delivery of GLP-1RA therapy in women results in a mean weight loss of 16.1 kg, or 15.5% of baseline weight, in a real-world UK cohort.
- Open access
A very-low-carbohydrate diet yields 2-3 times greater improvements in hepatic insulin sensitivity than Mediterranean or very-low-fat diets during 10% weight loss in metabolically unhealthy obesity.
Safiglipron at all tested doses is non-inferior to dapagliflozin in reducing HbA1c in adults with type 2 diabetes over 32 weeks.
- Open access
Effective obesity treatments, including new medications and procedures, are available but have not significantly reduced obesity rates in the US, which remain stable.
Add Pharmacology and Obesity Treatment as an interest in JClub
Browse JClub
Journals this month
- bioRxiv6183
- medRxiv1716
- PNAS472
- Sci Adv398
- JAMA274
- Environ Res230
- BMJ200
- Nat Commun171
- Environ Pollution165
- Nature161
- NEJM146
- Science141
- Lancet132
- Cell Rep130
- Curr Biol108
- J Exp Bot108
- mBio107
- Plant Cell Environ107
Topics moving, week to 23 Oct 2026
- Single-cell and spatial transcriptomics6
- Neuroinflammation and Neurodegeneration Mechanisms5
- Bacteriophages and microbial interactions5
- Gut microbiota and health5
- Genomics and Phylogenetic Studies4
- Cancer Genomics and Diagnostics4
- Cancer Immunotherapy and Biomarkers4
- Alzheimer's disease research and treatments3
- Inflammatory Bowel Disease3
- Influenza Virus Research Studies3